| DC Field | Value | Language |
|---|
| dc.contributor.author | Khokhlov, A. L. | - |
| dc.contributor.author | Yaichkov, I. I. | - |
| dc.contributor.author | Korsakov, M. K. | - |
| dc.contributor.author | Shetnev, A. A. | - |
| dc.contributor.author | Volkhin, N. N. | - |
| dc.date.accessioned | 2024-03-19T09:17:20Z | - |
| dc.date.available | 2024-03-19T09:17:20Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats / A.L. Khokhlov, I.I. Yaichkov, M.K. Korsakov [et al.] // Research Results in Pharmacology. - 2023. - Vol.9, №4.-P. 53-64. - Doi: 10.18413/rrpharmacology.9.10056. - Refer.: p. 63. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/61423 | - |
| dc.description.abstract | The developed methods have been fully validated according to the requirements of Russian and internatonal guidelines and have been successfully used for pharmacokinetic research. It was found that a content of 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide and its main metabolite in whole blood is significantly higher than in plasma | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | stabilization | ru |
| dc.subject | pharmacokinetics | ru |
| dc.subject | selective carbonic anhydrase II inhibitor | ru |
| dc.subject | ophthalmic suspension | ru |
| dc.subject | rats | ru |
| dc.title | Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 4
|
